Healthcare
Asia-Pacific Radioimmunoassay Market to 2032
Revenue, 2024 ()
60.82
Forecast, 2032 ()
65.80
CAGR, 2024 - 2032
0.99%
Report Coverage
Asia-Pacific
Asia-Pacific Radioimmunoassay Market 2018-2032
Asia-Pacific Radioimmunoassay Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 60.82
- Projected Market Size (2032): 65.80
- CAGR (2024-2032): 0.99%
Key Findings of Asia-Pacific Radioimmunoassay Market
- The Asia-Pacific Radioimmunoassay Market is likely to grow at a CAGR of 0.99% during the forecast period of 2024 to 2032.
- Asia-Pacific Radioimmunoassay Marketsize was valued at 60.82 in 2024.
- In 2024, Clinical Diagnosis segment dominated the market with the largest market share.
- Hospitals in the product segment is expected to witness the fastest growth during the forecast period.
Asia-Pacific Radioimmunoassay Market Scope
Asia-Pacific Radioimmunoassay Market Segmentation & Scope
End User
- Others
- Contract Research Organisations
- Pharmaceutical And Biopharmaceutical Industry
- Academic And Research Institutes
- Clinical Diagnostic Laboratories
- Hospitals
Distribution Channel
- Others
- Third Party Distributions
- Online Sales
- Direct Tender
Product
- Radio Immunoassay Analyzer
- Radio Immunoassay Reagents and Kits
Application
- Scientific Research
- Clinical Diagnosis
Asia-Pacific Radioimmunoassay Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in |
| Market Value in 2024 | 60.82 |
| Market Value in 2032 | 65.80 |
| CAGR (2024-2032) | 0.99% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Product,Application |
| Largest Segment | Clinical Diagnosis |
| Fastest Growing Segment | Hospitals |
| Major Players | Merck KGaA, PerkinElmer Inc., Tecan Trading AG, Beckman Coulter, Inc., Abcam Plc., Others |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Clinical Diagnosis
- Fastest Growing Segment (2024-2032): Hospitals
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific
- Key Country: China, leading in terms of revenue and market share by 2032.
Asia-Pacific Radioimmunoassay Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| PerkinElmer Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Tecan Trading AG | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Beckman Coulter | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Abcam Plc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Asia-Pacific Radioimmunoassay Market Geographical Sales Distribution, 2018-2032
Asia-Pacific Radioimmunoassay Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The Asia-Pacific Radioimmunoassay Market is segmented based on Segmentation End User,Distribution Channel,Product,Application.
Asia-Pacific Radioimmunoassay Market was valued at USD 60.82(Revenue in ) in 2021.
Asia-Pacific Radioimmunoassay Market is projected to grow at a CAGR of 0.99% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Radioimmunoassay Market for final year is USD 65.80 ().
Related Markets
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.